Tag: Neurodegeneration
Zydus Lifesciences completes Phase II(a) clinical trial of Usnoflast in ALS...
Usnoflast, a novel oral NLRP3 inflammasome inhibitor, shows promising results in reducing neurodegeneration and improving key health markers
Schrödinger & SPARC collaborate to accelerate neurodegeneration drug development program
Collaboration brings together Schrödinger’s in silico discovery capabilities with SPARC’s novel insights into CNS pathways to speed drug development..................